Therapeutic Management of Ocular Disease

Subject OPTO40007 (2010)

Note: This is an archived Handbook entry from 2010.

Credit Points: 12.50
Level: 4 (Undergraduate)
Dates & Locations:

This subject has the following teaching availabilities in 2010:

Semester 2, Parkville - Taught on campus.
Pre-teaching Period Start not applicable
Teaching Period not applicable
Assessment Period End not applicable
Last date to Self-Enrol not applicable
Census Date not applicable
Last date to Withdraw without fail not applicable

Timetable can be viewed here. For information about these dates, click here.
Time Commitment: Contact Hours: 12 x one hour lectures, 6 x two hour Computer Aided Learning practicals, and 12 x two hour seminars during the semester
Total Time Commitment: Estimated total time commitment of 120 hours
Prerequisites: Both of
Study Period Commencement:
Credit Points:
Corequisites: Both of
Study Period Commencement:
Credit Points:
Recommended Background Knowledge: None
Non Allowed Subjects: None
Core Participation Requirements: It is University policy to take all reasonable steps to minimise the impact of disability upon academic study and reasonable steps will be made to enhance a student’s participation in the University’s programs. Students who feel their disability may impact upon their active and safe participation in a subject are encouraged to discuss this with the relevant subject coordinator and the Disability Liaison Unit.


Dr Alex Gentle



Subject Overview:

The subject will consist of three components: Firstly, a lecture series to guide the student on the formulations available, the indications and contra-indications for their use and the current clinical protocols employed in the use of these formulations. Lecture topics covered will include anti-microbial, anti-viral, anti-inflammatory and anti-glaucoma medications; Secondly, a series of CAL practical sessions in which the student will be encouraged to apply knowledge gained in the lectures to a theoretical series of clinical situations; Thirdly, a series of seminars on the therapeutic management of ocular disease in which the students will prepare and present their management strategies in response to a variety of case histories and the supervising clinician will discuss current best-practice management associated with these cases and highlight issues associated with incorrect diagnosis. By the end of this subject the student will be required to have demonstrated a sound theoretical knowledge of the range and application of specific groups of therapeutic drugs in the management of eye disease.

Objectives: The purpose of this subject is to provide students with a sound knowledge of the range of prescription drugs used in the management of eye disease, along with the appropriate protocols and precautions necessary for their safe and effective clinical use.

A 10-minute oral presentation on a case report during the semester (20%); computer-aided learning assignments due during the semester (20%); a 2-hour written examination in the examination period (60%). An attendance rate of at least 80% is a hurdle requirement for each student for the Ophthalmology Seminar Series.

Prescribed Texts:
  • D Y Kunimoto et al, The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease, 5th Ed, Lippincott, Williams and Wilkins, 2008 (or 4th edition)
Recommended Texts:
  • A S Bruce and M S Loughnan, Anterior Eye Disease and Therapeutics A-Z, Butterworth Heinemann, 2003
  • Australian Medicines Handbook (AMH) , Latest Edition
Breadth Options:

This subject is not available as a breadth subject.

Fees Information: Subject EFTSL, Level, Discipline & Census Date

This subject is only available to Bachelor of Optometry students.

Related Course(s): Bachelor of Optometry

Download PDF version.